Surveillance Versus Treatment for Favorable Intermediate-Risk Prostate Cancer and Mortality-Risk
{{output}}
Background: Active surveillance (AS) is the preferred management approach for patients with low-risk prostate cancer (PC); yet whether younger patients with favorable-intermediate-risk (FIR) PC experience increased mortality-risk... ...
